Kyverna jumps after cell therapy meets main goal of mid-stage study - TradingView — Track All Markets

Reuters | Dec. 15, 2025, 6:53 a.m. | Original
Kyverna jumps after cell therapy meets main goal of mid-stage study TradingView — Track All Markets
Morning Bid: Stocks catch a break after bruising AI selloff - Reuters Siemens Energy can wait out its activist - TradingView — Track All Markets